EUVIMEDEUVIMED entdecken
Open Access

The GNB3 C825T Polymorphism Is Associated With Decreased Risk of Recurrence of Large‐Artery Atherosclerotic Acute Ischemic Stroke

Ran Yan, Xin Qiu, Yalun Dai iD, Kaixuan Yang iD, Hongqiu Gu iD, Yong Jiang iD, Si Cheng iD, Xia Meng iD, Yilong Wang iD, Xingquan Zhao iD, Hao Li iD, Yongjun Wang iD und 1 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.047271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Ran Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China. Hauptthemen laut MEDLINE: Heterotrimeric GTP-Binding Proteins, Ischemic Stroke, Brain Ischemia, Intracranial Arteriosclerosis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

GNB3 C825T polymorphism affects G protein–coupled receptor signaling, influencing platelet function, inflammation, and cardiovascular risk. This study aimed to investigate the unknown effects of the GNB3 C825T polymorphism on recurrent stroke risk in large‐artery atherosclerosis and its potential interaction with antiplatelet therapy.

Methods

Using the CNSR‐III (Third China National Stroke Registry) data, we analyzed 1233 patients with large‐artery atherosclerotic acute ischemic stroke enrolled within 72 hours of onset. Whole‐genome sequencing was performed to identify the GNB3 C825T polymorphism. Cox regression analysis was used to assess its association with 1‐year recurrent ischemic stroke after adjusting for vascular risk factors. Associations with antiplatelet regimens and mediating effects of inflammatory biomarkers in the overall cohort were also evaluated.

Results

Carriers of the GNB3 825T‐allele (CT/TT, 72.7%) exhibited a significantly lower risk of 1‐year recurrent ischemic stroke than noncarriers (adjusted hazard ratio, 0.67 [95% CI, 0.48–0.93]; P =0.02). In exploratory analyses, the association was observed in the aspirin monotherapy subgroup, but the interaction with aspirin use was not significant. Elevated baseline interleukin‐6 partially attenuated this genetic protection in the overall cohort (mediation proportion, –9.82%; P =0.02).

Conclusions

The GNB3 825T‐allele was associated with a reduced risk of recurrent stroke in patients with large‐artery atherosclerotic acute ischemic stroke. In exploratory analyses, this association was observed in the aspirin monotherapy subgroup; however, the formal interaction with aspirin use was not statistically significant. These findings support a potential prognostic role of the GNB3 C825T polymorphism and warrant further validation in independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterotrimeric GTP-Binding ProteinsIschemic StrokeBrain IschemiaIntracranial ArteriosclerosisAtherosclerosisHumansFemaleMaleRecurrenceRisk FactorsAgedMiddle AgedPlatelet Aggregation InhibitorsChinaGenetic Predisposition to DiseaseRegistriesPolymorphism, Single NucleotideRisk AssessmentStrokeAspirin

Stichwörter der Autor:innen

GNB3 C825T polymorphismGNB3 geneacute ischemic strokeaspirininterleukin‐6large‐artery atherosclerosis

Substanzen

Heterotrimeric GTP-Binding ProteinsGNB3 protein, humanPlatelet Aggregation InhibitorsAspirin

Autor:innen und Institutionen

  • Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China.
  • China National Clinical Research Center for Neurological Diseases Beijing China.
  • National Center for Healthcare Quality Management in Neurological Diseases Beijing China.
  • Advanced Innovation Center for Human Brain Protection Capital Medical University Beijing China.
  • Center for Stroke, Beijing Institute for Brain Disorders Beijing China.
  • Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences Beijing China.

ORCID-Profile: Yalun Dai, Kaixuan Yang, Hongqiu Gu, Yong Jiang, Si Cheng, Xia Meng, Yilong Wang, Xingquan Zhao, Hao Li, Yongjun Wang, Zixiao Li

Zitieren

APA

Yan, R., Qiu, X., Dai, Y., Yang, K., Gu, H., Jiang, Y., Cheng, S., Meng, X., Wang, Y., Zhao, X., Li, H., Wang, Y., & Li, Z. (2026). The GNB3 C825T Polymorphism Is Associated With Decreased Risk of Recurrence of Large‐Artery Atherosclerotic Acute Ischemic Stroke. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047271

Vancouver

Yan R, Qiu X, Dai Y, Yang K, Gu H, Jiang Y, et al. The GNB3 C825T Polymorphism Is Associated With Decreased Risk of Recurrence of Large‐Artery Atherosclerotic Acute Ischemic Stroke. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047271

BibTeX
@article{Yan2026,
  author = {Yan, Ran and Qiu, Xin and Dai, Yalun and Yang, Kaixuan and Gu, Hongqiu and Jiang, Yong and Cheng, Si and Meng, Xia and Wang, Yilong and Zhao, Xingquan and Li, Hao and Wang, Yongjun and Li, Zixiao},
  title = {The GNB3 C825T Polymorphism Is Associated With Decreased Risk of Recurrence of Large‐Artery Atherosclerotic Acute Ischemic Stroke},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.047271}
}
Kostenlos starten →